Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine versus opioid anesthesia for recovery quality and postoperative anxiety/depression after laparoscopic total hysterectomy
ChiCTR2300075661Phase 4Not yet recruiting
- Sponsor
- Changzhi People's Hospital
- Start
- Jul 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, sufentanil, remifentanil, propofol and rocuronium in postoperative pain, anxiety disorder and postoperative depression (2 arms), sponsored by Changzhi People's Hospital. Primary endpoints: Postoperative Recovery Quality Scale (QoR-40), Hospital Anxiety and Depression Scale (HADS-A/HADS-D) and 2 more. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
esketaminesufentanilremifentanilpropofolrocuronium
03
Conditions
postoperative painanxiety disorderpostoperative depression
Beyond the preview
Go deeper on ChiCTR2300075661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075661.